How many institutions own MEDS stock?

A company's 13F filings with the Securities and Exchange Commission (SEC) provides investors with comprehensive information about institutional ownership in a listed company, a sign of strength in terms of how many institutions have confidence in that company. The number of institutional investors who currently own MEDS shares is 7, representing 6.92% of the company's common stock.

Who are the major shareholders selling TRxADE HEALTH, Inc. stock?

CITIGROUP INC, in the last quarter, reduced its stake in MEDS by -100% restricting it's holding to 0 shares of worth nearly -. GEODE CAPITAL MANAGEMENT, LLC also lessened -100% of the MEDS shares from its portfolio, reducing its holding to 0 shares of worth -. SUSQUEHANNA INTERNATIONAL GROUP, LLP also shunned MEDS shares holding by -100% last quarter which brought its holding to 0 shares worth -.

Investors who are buying MEDS stock?

As per its latest 13F filing, N/A increased its stake in MEDS by N/A in the last quarter. The institutional holder raised its holding to - shares having worth more than -. N/A also added N/A more shares of MEDS to its portfolio, raising its holding to - shares of worth -. N/A also increased its MEDS shares holding by N/A which brought its holding to - shares worth -.

MEDS's major insiders: who are they?

The insider with the most stakes in MEDS is Patel Prashant , President at the company. Additionally, MEDS stock is highly held by CEO AJJARAPU SURENDRA K and Fell Donald G. among others.

Did an insider recently sell MEDS stock?

Company executives, directors, and other insiders own 61.7% percent of TRxADE HEALTH, Inc.'s stock. Within the last six months, there have been 0 transaction(s) in which MEDS insiders have sold stock, totaling 0 shares. Insiders that have sold shares include PETERSON MICHAEL L, PATEL PRASHANT, and TENAERTS PAMELA.

Which insider recently purchased MEDS stock?

There have been 0 transaction(s) during the past 6-months in which TRxADE HEALTH, Inc. insiders have bought stock, totalling 0 shares

How much of MEDS does insiders own?

Around 0 TRxADE HEALTH, Inc. shares are held by insiders, which represents about 61.7% of MEDS stock.

Who is the insider with the largest stake?

MEDS President, Patel Prashant holds the largest portfolio of the company's shares. MEDS shares owned by Patel total nearly 1.25 million.

Which institution holds the most shares in MEDS?

RONALD BLUE TRUST, INC. is the largest institutional owner in MEDS which holds 5.35 thousand shares worth $2.00K or 0.05% of the total MEDS shares outstanding followed by CITIGROUP INC with ownership of 0 shares representing 0% of the MEDS ownership. GEODE CAPITAL MANAGEMENT, LLC is the third largest stakeholder with 0 shares or 0% of the ownership worth more than -.

Is TRxADE HEALTH, Inc. stock optionable?

Stock options give the owner the ability but not the obligation to buy or sell a security at a predetermined price and date. Stock options can be classified into two types: puts and calls. A put is a bet on falling stock, and a call is a bet on rising stock. As far as the MEDS is concerned, it is a stock which is not optionable.

Is there a short position on MEDS's shares?

Number of MEDS shares short is 15.00K. Shares short is a market sentiment in which investors have sold their shares short in a given stock but have not yet covered them or closed them out.

About how many outstanding MEDS shares are there?

As of today, 1.75M shares of MEDS are outstanding.

Is there many float in MEDS stock?

Float represents the number of tradeable shares in a specific stock. By subtracting restricted and closely-held shares from a firm's total outstanding shares, we can calculate its floating stock. The term "closely-held shares" refers to shares held by employees, major shareholders, and company insiders. At present, MEDS has 734.54K shares in float.

MEDS short ratio: what is it?

Short ratio is calculated by dividing the number of short shares, short interest or bets that shareholders will sell short from the average daily volume. A higher ratio indicates longer times needed to repurchase borrowed shares (sold). The short ratio for MEDS is 0.28.

Stock Ideas

MEDS Stock Ownership Breakdown

NASDAQ : MEDS

TRxADE HEALTH

$7.59

0.33+4.55%

At Close 4:00 PM

Not Actively Trading

61.07

B-ESG ScoreESG Rating

Profile Key Stats Analyst Ratings Ownership Ratios Financials Dividend & splits Sentiment Forecast

Stock Outstanding Shares

Making an investment decision in the stock market involves a certain amount of risk, so it's important to thoroughly review a company's stock before making any decisions. Stock float, number of short positions and outstanding shares are among the many factors an investor should take into account.

ShortableYes

OptionableNo

Short Percent Of Outstanding Shares0.86

Short Percent Of Float1.13

Shares Outstanding1.75M

Shares Float734.54K

Shares Short15.00K

Short Ratio0.28

1.13%

Short % of Float

0.86%

Short % of Shares Outstanding

Market Insider

Investors cannot turn a blind eye to insiders as well as institutional ownership. They need to follow insider trades to determine the direction the stock is likely to take.

Major Holders Summary

61.7% Percentage of Shares held by All Insiders

6.92% Percentage of Shares held by All Institutions

18.07% Percentage of Float held by Institutions

Number of Institutions Holding Shares

Institutional Ownership

About 6.92% of MEDS shares are held by financial institutions. RONALD BLUE TRUST, INC. is the top corporate investor, holding 5.35K shares valued at $2.00K. A 0.05% stake in TRxADE HEALTH, Inc. is owned by the company. CITIGROUP INC owns 0 shares valued at -, which translates its holding of 0% of the stake in the company.

Date	Holder	% Stake	Shares Held	Total Value ($)	Shares	% Change in Portfolio
Jun 30, 2023	RONALD BLUE TRUST, INC.	0.05%	5.35K	2K	0	0
Jun 30, 2023	CITIGROUP INC	0%	0	-	-4.17K	-100.00%
Jun 30, 2023	GEODE CAPITAL MANAGEMENT, LLC	0%	0	-	-42.06K	-100.00%
Jun 30, 2023	SUSQUEHANNA INTERNATIONAL GROUP, LLP	0%	0	-	-19.58K	-100.00%
Jun 30, 2023	TOWER RESEARCH CAPITAL LLC (TRC)	0%	0	-	-17.75K	-100.00%
Jun 30, 2023	SPIRE WEALTH MANAGEMENT	0%	0	-	-2.46K	-100.00%
Jun 30, 2023	B. RILEY WEALTH ADVISORS, INC.	0%	0	-	-48.28K	-100.00%
Jun 30, 2023	WELLS FARGO & COMPANY/MN	0%	0	-	-31	-100.00%
Jun 30, 2023	VANGUARD GROUP INC	0%	0	-	-39.63K	-100.00%
Jun 30, 2023	VIRTU FINANCIAL LLC	0%	0	-	-25.11K	-100.00%
Jun 30, 2023	WEALTH DIMENSIONS GROUP, LTD.	0%	0	-	-30.98K	-100.00%

Insiders

Among the MEDS insiders holding of 61.7% of the stake in company, PATEL PRASHANT, President, holds the largest shares of 1.25M. AJJARAPU SURENDRA K, CEO, is the second largest MEDS insider with ownership of 222.5K shares. FELL DONALD G., , stands third with possession of 21.14K shares of that stake.

Insiders	Designation	Shares Held
PATEL PRASHANT	President	1.25M
AJJARAPU SURENDRA K	CEO	222.5K
FELL DONALD G.		21.14K
TENAERTS PAMELA	director	8.19K
PETERSON MICHAEL L		5.39K

Buying/Selling by Insiders

Date	Insider	Type	Cost	Shares	Value ($)	Shares Total
Aug 25, 2022	FELL DONALD G.	PURCHASE	1.08	1.5K	1.62K	21.14K
May 20, 2022	AJJARAPU SURENDRA K	PURCHASE	13000.00	10K	130M	222.5K
May 12, 2022	FELL DONALD G.	PURCHASE	1.26	2K	2.52K	19.64K
Jun 21, 2021	PETERSON MICHAEL L	SALE	4.45	900	4.01K	5.39K
Apr 19, 2021	PETERSON MICHAEL L	SALE	4.68	900	4.21K	6.29K
Apr 19, 2021	PATEL PRASHANT	SALE	4.39	7.5K	32.91K	1.25M
Dec 14, 2020	PATEL PRASHANT	SALE	5.29	7.5K	39.7K	1.26M
Dec 14, 2020	TENAERTS PAMELA	SALE	5.30	800	4.24K	8.19K
Dec 14, 2020	PETERSON MICHAEL L	SALE	5.26	1.8K	9.46K	7.19K
Dec 14, 2020	FELL DONALD G.	SALE	5.30	500	2.65K	8.49K
Jul 14, 2020	PATEL PRASHANT	SALE	5.44	7K	38.08K	1.27M
Jul 13, 2020	PATEL PRASHANT	SALE	5.71	500	2.86K	1.27M
Oct 08, 2019	FELL DONALD G.	SALE	1.00	1K	1K	1.58K
Aug 05, 2019	FELL DONALD G.	SALE	0.55	1K	550	3.28K
Jul 02, 2019	FELL DONALD G.	SALE	0.62	200	124	4.28K
Jun 11, 2019	FELL DONALD G.	SALE	0.54	1K	540	4.08K
Feb 05, 2019	FELL DONALD G.	SALE	0.55	2K	1.1K	3.78K
Dec 20, 2018	FELL DONALD G.	SALE	0.26	3	0.78	2.48K
Jan 24, 2018	FELL DONALD G.	SALE	0.37	400	148	2.48K
Dec 20, 2017	FELL DONALD G.	SALE	0.44	800	352	2.08K
Nov 15, 2017	AJJARAPU SURENDRA K	SALE	112500.00	250K	28.13B	13.74M
Mar 30, 2017	FELL DONALD G.	SALE	0.25	4	1	1.28K
Mar 15, 2017	FELL DONALD G.	SALE	0.30	500	150	1.27K
Mar 07, 2017	FELL DONALD G.	SALE	0.42	500	210	774

Frequently Asked Questions

Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.

Stocks Telegraph does not provide any advice or recommendations for buying or selling stocks, securities, or other financial products. Information contained on this website is for informational purposes only and should not be construed as professional financial, investment or other advice. Stocks Telegraph is not liable for any loss or damage that may occur as a result of reliance on this data.